NeuroSense Therapeutics Ltd. (NRSNW) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$7.67M | +24.3% |
| 2024 | -$10.13M | -21.3% |
| 2023 | -$8.35M | -9.7% |
| 2022 | -$7.62M | -394.9% |
| 2021 | -$1.54M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$7.67M | +24.3% |
| 2024 | -$10.13M | -21.3% |
| 2023 | -$8.35M | -9.7% |
| 2022 | -$7.62M | -394.9% |
| 2021 | -$1.54M | — |